Japara Healthcare
(ASX:JHC) is reporting a 15 per cent jump in revenue and higher than expected earnings.
Net profit after tax came in at $28.8 million while EBITDA was 26 per cent higher at $50.6 million above guidance of $50.3 million.
The company successfully beat its prospectus forecasts offsetting headwinds presented by the removal of Payroll Tax and Dementia Supplements with a solid operating performance and a strong result from the recently acquired Whelan Care Business.
A final dividend of 5.5 cents per share brings the full year dividend to 11 cents per share up on guidance of 10.5 cents per share.
